Cancer

Base Molecular Resonance™ Technologies Receives $1.8 Billion U.S. IP Licensing Valuation in its Security Business Sector

Report Cites Projections of an Additional $3.5 Billion Upon Global Expansion STUART, Fla., Oct. 21, 2024 /PRNewswire/ -- Base Molecular…

1 year ago

LINDIS Biotech Receives Positive CHMP Opinion for KORJUNY(R) (catumaxomab) in the European Union

Upon authorization by the European Commission, KORJUNY® will be the only drug approved and available for the intraperitoneal treatment of…

1 year ago

Nomination Committee Appointed for Spago Nanomedical’s Annual General Meeting 2025

LUND, SE / ACCESSWIRE / October 21, 2024 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) In accordance with the instructions to the nomination…

1 year ago

Global Health Exhibition Opens its Doors Tomorrow to Record-Breaking 100,000+ Attendees to World’s Premier Healthcare Transformation Event

Kingdom of Saudi Arabia opens the Global Health Exhibition (21-23 October 2024) tomorrow, a major international healthcare event with 100,000+…

1 year ago

Lena Esmail Advocates for Expanding Healthcare Access in Underserved Communities: A Call to Support QuickMed’s Innovative Approach

Lena Esmail is a healthcare innovator and the CEO of QuickMed, which she founded in 2018. YOUNGSTOWN, OH / ACCESSWIRE…

1 year ago

KFSHRC Pioneers Cancer Treatment with Breakthrough Therapies and Exceptional Outcomes

RIYADH, Saudi Arabia, Oct. 19, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) is revolutionizing cancer…

1 year ago

Nurix Therapeutics Presents Positive Results from the Ongoing Clinical Trial of Its BTK Degrader NX-5948 in Patients with Relapsed/Refractory Waldenstrom’s Macroglobulinemia

NX-5948 demonstrated robust clinical activity with objective responses observed in 7 of 9 (77.8%) evaluable Waldenstrom’s patients in the ongoing…

1 year ago

NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS)

SAN DIEGO, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing…

1 year ago

Celularity Inc. Receives Notice from Nasdaq; Confirms Intention to File an Appeal

FLORHAM PARK, N.J., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (the “Company”), a regenerative medicine company developing and commercializing…

1 year ago